Electronic Journal of Liver Tumor ›› 2021, Vol. 8 ›› Issue (4): 1-5.
• Review of experts • Next Articles
Zheng Bowen, Zheng Shuguo*
Received:
2021-12-13
Online:
2021-12-30
Published:
2022-10-27
Zheng Bowen, Zheng Shuguo. Current status and consideration of laparoscopic anatomical liver resection for hepatocellular carcinoma[J]. Electronic Journal of Liver Tumor, 2021, 8(4): 1-5.
[1] TANG A, HALLOUCH O, CHERNYAK V, et al.Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis[J]. Abdom Radiol (NY), 2018, 43(1): 13-25. [2] ZENG H, CHEN W, ZHENG R, et al.Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries[J]. Lancet Glob Health, 2018, 6(5): e555-e567. [3] JIAO S, LI G, ZHANG D, et al.Anatomic [4] HIBI T, CHERQUI D, GELLER D A, et al.Expanding indications and regional diversity in laparoscopic liver resection unveiled by the International Survey on Technical Aspects of Laparoscopic Liver Resection (INSTALL) study[J]. Surg Endosc, 2016, 30(7): 2975-2983. [5] MAKUUCHI M. Surgical treatment for HCC--special reference to anatomical resection[J]. Int J Surg, 2013, 11 Suppl 1: S47-S49. [6] MORIS D, TSILIMIGRAS D I, KOSTAKIS I D, et al.Anatomic [7] FENG X, SU Y, ZHENG S, et al.A double blinded prospective randomized trial comparing the effect of anatomic [8] HUANG X, LU S.A Meta-analysis comparing the effect of anatomical resection [9] KANG K J, AHN K S.Anatomical resection of hepatocellular carcinoma: A critical review of the procedure and its benefits on survival[J]. World J Gastroenterol, 2017, 23(7): 1139-1146. [10] HOKUTO D, NOMI T, YASUDA S, et al.Does anatomic resection improve the postoperative outcomes of solitary hepatocellular carcinomas located on the liver surface?[J]. Surgery, 2018, 163(2): 285-290. [11] MATSUMOTO T, KUBOTA K, AOKI T, et al.Clinical Impact of Anatomical Liver Resection for Hepatocellular Carcinoma with Pathologically Proven Portal Vein Invasion[J]. World J Surg, 2016, 40(2): 402-411. [12] HASEGAWA K, KOKUDO N, IMAMURA H, et al.Prognostic Impact of Anatomic Resection for Hepatocellular Carcinoma[J]. Ann Surg, 2005, 242(2): 252-259. [13] KAIBORI M, KON M, KITAWAKI T, et al.Comparison of anatomic and non-anatomic hepatic resection for hepatocellular carcinoma[J]. J Hepatobiliary Pancreat Sci, 2017, 24(11): 616-626. [14] 王晓耘, 马增辉, 史佩东. 解剖性肝段切除术关键技术和争议[J/OL]. 中华肝脏外科手术学电子杂志, 2020, 9(4): 317-320. [15] KANG W, KIM K, JUNG D, et al.Long-term results of laparoscopic liver resection for the primary treatment of hepatocellular carcinoma: role of the surgeon in anatomical resection[J]. Surg Endosc, 2018, 32(11): 4481-4490. [16] ISHIZAWA T, GUMBS A A, KOKUDO N, et al.Laparoscopic Segmentectomy of the Liver[J]. Ann Surg, 2012, 256(6): 959-964. [17] XIANG L, XIAO L, LI J, et al.Safety and Feasibility of Laparoscopic Hepatectomy for Hepatocellular Carcinoma in the Posterosuperior Liver Segments[J]. World J Surg, 2015, 39(5): 1202-1209. [18] XIAO L, XIANG L, LI J, et al.Laparoscopic versus open liver resection for hepatocellular carcinoma in posterosuperior segments[J]. Surg Endosc, 2015, 29(10): 2994-3001. [19] SONG J, WANG Y, MA K, et al.Laparoscopic hepatectomy versus radiofrequency ablation for minimally invasive treatment of single, small hepatocellular carcinomas[J]. Surg Endosc, 2016, 30(10): 4249-4257. [20] MORISE Z, WAKABAYASHI G.First quarter century of laparoscopic liver resection[J]. World J Gastroenterol, 2017, 23(20): 3581-3588. [21] RYU T, HONDA G, KURATA M, et al.Perioperative and oncological outcomes of laparoscopic anatomical hepatectomy for hepatocellular carcinoma introduced gradually in a single center[J]. Surg Endosc, 2018, 32(2): 790-798. [22] 郑树国. 腹腔镜肝切除术肝静脉系统出血处理策略[J]. 中国实用外科杂志, 2017, 37(5): 485-489. [23] 乔婷, 王峻峰. 影像组学在肝癌中的研究应用[J]. 影像研究与医学应用, 2021, 5(11): 1-2. [24] 罗湘, 李涛, 朱继业, 等. 三维重建在精准肝切除治疗复杂原发性肝癌术前评估中的应用[J]. 中华医学杂志, 2021, 101(28): 2210-2215. [25] MAKUUCHI M, HASEGAWA H, YAMAZAKI S.Ultrasonically guided subsegmentectomy[J]. Surg Gynecol Obstet, 1985, 161(4): 346-350. [26] XU Y, CHEN M, MENG X, et al.Laparoscopic anatomical liver resection guided by real-time indocyanine green fluorescence imaging: experience and lessons learned from the initial series in a single center[J]. Surg Endosc, 2020, 34(10): 4683-4691. [27] CHIOW A, RHO S Y, WEE I, et al.Robotic ICG guided anatomical liver resection in a multi-centre cohort: an evolution from "positive staining" into "negative staining" method[J]. HPB (Oxford), 2021, 23(3): 475-482. [28] KALIL J A, POIRIER J, BECKER B, et al.Laparoscopic Parenchymal-Sparing Hepatectomy: the New Maximally Minimal Invasive Surgery of the Liver-a Systematic Review and Meta-Analysis[J]. J Gastrointest Surg, 2019, 23(4): 860-869. [29] BERARDI G, IGARASHI K, LI C J, et al.Parenchymal Sparing Anatomical Liver Resections With Full Laparoscopic Approach: Description of Technique and Short-term Results[J]. Ann Surg, 2021, 273(4): 785-791. [30] CONRAD C, OGISO S, INOUE Y, et al.Laparoscopic parenchymal-sparing liver resection of lesions in the central segments: feasible, safe, and effective[J]. Surg Endosc, 2015, 29(8): 2410-2417. |
[1] | Shi Wenwu, Chen Zhimin, Zhou Jinhua. Bioinformatics analysis and validation of key genes in the pathogenesis and prognosis of hepatocellular carcinoma [J]. Electronic Journal of Liver Tumor, 2022, 9(3): 1-6. |
[2] | Song Zengfu, Zhao Liang, Xu Haitao, Zhao Haoran, Wang Peng, Wang Yunfeng, Zhang Yubao. Perioperative safety and feasibility analysis of laparoscopic hepatectomy ofⅧ segment hepatocellular carcinoma [J]. Electronic Journal of Liver Tumor, 2022, 9(3): 7-11. |
[3] | Wei Wei, Cui Chen, Liu Xiulian, Han Guijie, Pan Jing, Gao Yanping, Zhang Jingjing, Wang Yuan. Investigation and influencing factors of postoperative fatigue in patients with hepatocellular carcinoma after liver transplantation [J]. Electronic Journal of Liver Tumor, 2022, 9(3): 22-26. |
[4] | Liang Qianjing, Wu Deping, Wang Shengjie, Yan Kangming, Deng Lili, Han Shanshan. Prediction of pain intensity after transarterial chemoembolization in patients with hepatocellular carcinoma by neutrophil to lymphocyte ratio-platelet to lymphocyte ratio score [J]. Electronic Journal of Liver Tumor, 2022, 9(3): 27-35. |
[5] | Huang Di, Wu Xueliang, Li Fei, Han Shanshan, Gao Xin. The role of nucleotide binding oligomerization domain like receptor protein 6 in the prognosis of hepatocellular carcinoma based on bioinformatics analysis [J]. Electronic Journal of Liver Tumor, 2022, 9(2): 13-22. |
[6] | Huang Xiaozhun, Wang Chunling, Liu Yibin, Li Xiaoqing, Huang Zhangkan, Xu Lin, Ni Yong, Che Xu, Bi Xinyu. Research progress of spontaneous ruptured hepatocellular carcinoma [J]. Electronic Journal of Liver Tumor, 2022, 9(2): 23-27. |
[7] | Zhao Xiaoyun, Jin Yong, Chen Xiangfeng, Huang Hui, Zhou Huimin. Construction and application of activity program for relieving bed restriction in hepatic arterial infusion chemotherapy treatment [J]. Electronic Journal of Liver Tumor, 2022, 9(2): 35-40. |
[8] | Wang Yuxin, Xing Jiali, Liu Xiao, Wan Xueshuai, Zheng Yongchang, Xu Haifeng, Du Shunda, Mao Yilei. A meta-analysis of the safety and effectiveness of laparoscopic liver resection for lesions located in posterosuperior versus anterolateral segments [J]. Electronic Journal of Liver Tumor, 2021, 8(4): 6-12. |
[9] | Peng Yufu, Liu Fei, Li Bo, Wei Yonggang. Laparoscopic versus open liver resection for resectable multiple hepatocellular carcinomas beyond Milan criteria [J]. Electronic Journal of Liver Tumor, 2021, 8(4): 13-16. |
[10] | Leng Songyao, Cao Li, Tian Feng, Wang Xiaojun, Chen Jian, Zheng Shuguo, Li Jianwei. Laparoscopic versus open mesohepatectomy for centrally located hepatocellular carcinoma: a propensity score matching study [J]. Electronic Journal of Liver Tumor, 2021, 8(4): 17-20. |
[11] | Yu Yue, Huang Huiyao, Wu Dawei, Wang Shuhang, Yu Anqi, Fan Qi, Bai Ying, Du Jingting, Fang Yuan, Jiang Ning, Fang Hong, Tang Yu, Li Ning. Progress on clinical trials of anticancer drug for hepatocellular carcinoma in China during the 13th Five-Year Plan Period [J]. Electronic Journal of Liver Tumor, 2021, 8(4): 26-30. |
[12] | Dou Xiaowei, Wang Qiang, Pu Changsheng, Shi Wenzai, Suo Xiaopeng, Wu Xianjia, Wu Tiantian, Cai Jun, Cheng Zhilei, Tian Yuanhu, Chen Jianfei, Zhang Keming. Progress of application of real-time virtual navigation system combined with indocyanine green staining in anatomical liver resection of primary hepatic carcinoma [J]. Electronic Journal of Liver Tumor, 2021, 8(4): 31-35. |
[13] | Jiang Tao, Pan Fei, Chen Qing, Huang Jincan, He Qiang, Lang Ren. Clinical study on individualized medication of tacrolimus after liver transplantation guided by CYP3A5 gene polymorphism for hepatocellular carcinoma [J]. Electronic Journal of Liver Tumor, 2021, 8(3): 8-11. |
[14] | Zhou Lin, Wang Jing, Zhao Yang, Li Han, Du Guosheng, Shi Xianjie, He Qiang, Lang Ren. HIF-1α is a negative prognostic indicator associated with poor survival benefits of HCC patients [J]. Electronic Journal of Liver Tumor, 2021, 8(3): 17-25. |
[15] | Xiong Jun, Wan Chidan. Immune checkpoint inhibitors in liver transplantation patients with hepatocellular carcinoma [J]. Electronic Journal of Liver Tumor, 2021, 8(3): 30-34. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||